For the Inventor, By the Inventor

Enter assignee name

San Jose, CA, United States of America

Teikoku Pharma USA, Inc.

USPTO Granted Patents = 52

% Expired Patents = 40.4

CIPO Patents = 11

EPO Patents = 17

Trademarks = 9

Forward Citations = 205

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Jutaro Shudo (16 out of 16 patents)

Jianye Wen (13 out of 19 patents)

Carter R Anderson (12 out of 32 patents)

4. Russell L Morris (9 out of 28 patents)

5. Amit K Jain (8 out of 27 patents)

6. Kiichiro Nabeta (8 out of 9 patents)

7. Bret Berner (7 out of 65 patents)

8. Adchara Pongpeerapat (7 out of 8 patents)

9. Richard D Hamlin (7 out of 9 patents)

10. Kensuke Murata (5 out of 5 patents)

11. William V Fowler (4 out of 16 patents)

12. Sadanobu Shirai (3 out of 9 patents)

13. Robert Cohen (3 out of 6 patents)

14. John Koo (3 out of 3 patents)

15. Toru Hibi (3 out of 3 patents)

Core Competencies:

Dexmedetomidine

Transdermal Delivery

Topical Formulations

Pain Management

Sphingosine-1-Phosphate

Rivastigmine

Taxane Formulations

Iontophoresis

Narcotic Emulsions

Dermatological Agents

Medication Disposal

Hormonal Delivery

52 patents: Sort by Forward Citations

1. 12527770 - Methods of managing pain using dexmedetomidine transdermal delivery devices (2026-01-20),

2. 12364692 - Topical naloxone compositions and methods for using the same (2025-07-22),

3. 10987342 - Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine (2021-04-27),

4. 10918607 - Propynylaminoindan transdermal compositions (2021-02-16),

5. 10874642 - Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions (2020-12-29),

6. 10842770 - Non-aqueous taxane pro-emulsion formulations and methods of making and using the same (2020-11-24),

7. 10772871 - Dexmedetomidine transdermal delivery devices and methods for using the same (2020-09-15),

8. 10617655 - Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same (2020-04-14),

9. 10357463 - Rivastigmine transdermal compositions and methods of using the same (2019-07-23),

10. 10188616 - Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same (2019-01-29),

11. 10022340 - Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same (2018-07-17),

12. 9949935 - Rivastigmine transdermal compositions and methods of using the same (2018-04-24),

13. 9913812 - Methods for the treatment of skin neoplasms (2018-03-13),

14. 9827207 - Propynylaminoindan transdermal compositions (2017-11-28),

15. 9763880 - Non-aqueous taxane formulations and methods of using the same (2017-09-19),

Company Overview

Teikoku Pharma USA, Inc., based in San Jose, California, specializes in the development and manufacturing of advanced transdermal drug delivery systems. The company focuses on innovative topical formulations that enhance the delivery of various therapeutic agents, including dexmedetomidine and rivastigmine, aimed at pain management and other medical applications. With expertise in technologies such as iontophoresis and taxane formulations, Teikoku Pharma is committed to improving patient outcomes through effective and reliable drug delivery solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

52 Patents

#181 in San Jose, CA

#1,589 in California

#6,764 in US

#13,555 in the World

San Jose, CA, United States of America

Teikoku Pharma USA, Inc.

Forward Citations = 205

35 inventors:

Jutaro Shudo (16 out of 16 patents)

Jianye Wen (13 out of 19 patents)

Carter R Anderson (12 out of 32 patents)

4. Russell L Morris (9 out of 28 patents)

5. Amit K Jain (8 out of 27 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Teikoku Pharma USA, Inc.. Retrieved from https://idiyas.com/company/teikoku-pharma-usa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…